BPC-157
Frequently Bought Together
BPC-157 by BeaCapra — premium research-grade compound verified to ≥99.0% purity via independent HPLC and LC-MS analysis.
Supplied as lyophilized (freeze-dried) powder in vacuum-sealed glass vials. Each batch undergoes rigorous third-party testing to ensure pharmaceutical-grade consistency and stability.
Specifications
- Purity: ≥99.0% (HPLC verified)
- Form: Lyophilized Powder
- Category: Recovery Research
- Storage: -20°C recommended, protect from light
Quality Assurance
Every BeaCapra product ships with a Certificate of Analysis (COA) documenting purity verification via HPLC and mass spectrometry. Our compounds are synthesized under strict GMP-adjacent protocols and undergo batch-level quality control.
For Research Use Only (RUO). Not intended for human consumption, therapeutic, or diagnostic use.
Research-Documented Benefits
- Tissue Repair & Regeneration — Demonstrated accelerated healing of muscle, tendon, ligament, and bone tissue in multiple preclinical models. Studies show enhanced angiogenesis and granulation tissue formation at injury sites.
- Gastrointestinal Protection — Derived from gastric juice proteins, BPC-157 has shown cytoprotective effects on the GI mucosa, including protection against NSAID-induced lesions and ethanol damage in animal models.
- Neuroprotective Properties — Research indicates potential protection against cuprizone-induced demyelination and dopaminergic system damage. Studies in rodent models show improved outcomes following traumatic brain injury.
- Anti-Inflammatory Activity — Modulates inflammatory cytokine expression and has demonstrated reduced edema and inflammatory cell infiltration in multiple tissue injury models.
- Vascular Support — Promotes formation of new blood vessels via VEGF upregulation, supporting nutrient delivery to damaged tissues during the repair process.
Mechanism of Action
BPC-157 is a stable pentadecapeptide (15 amino acids) derived from human gastric juice proteins. Unlike many bioactive peptides, BPC-157 is resistant to enzymatic degradation in the GI tract, making it stable under physiological conditions.
Primary Pathways
- Growth Factor Upregulation — BPC-157 stimulates expression of vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and epidermal growth factor receptor (EGFR), promoting angiogenesis and tissue remodeling.
- Nitric Oxide System — Modulates the NO system, mediating vasodilation, blood flow to injured tissues, and inflammatory response regulation. Interacts with both NOS-dependent and NOS-independent pathways.
- FAK-Paxillin Pathway — Activates focal adhesion kinase (FAK) and its downstream target paxillin, promoting cell migration, adhesion, and cytoskeletal reorganization necessary for wound repair.
- Dopaminergic System — Interacts with dopamine D1 and D2 receptor systems, which may underlie its documented neuroprotective and antidepressant-like effects in animal models.
BPC-157 appears to act as a master regulator of repair cascades, engaging multiple redundant pathways simultaneously rather than targeting a single receptor.
Research Protocol Guidelines
All protocols described are for in vitro and in vivo research purposes only. Not for human use.
Reconstitution
Reconstitute lyophilized BPC-157 with bacteriostatic water (0.9% benzyl alcohol). For a 5 mg vial, adding 2 mL bacteriostatic water yields a concentration of 2.5 mg/mL (2,500 mcg/mL). Allow powder to dissolve gently—do not shake or vortex.
Research Dosing (Preclinical Literature)
- Standard range: 1-10 mcg/kg body weight, administered subcutaneously or intraperitoneally in rodent models
- Common research dose: 10 mcg/kg, administered once or twice daily
- Study durations: Typically 7-30 days in preclinical injury and healing models
- Routes studied: Subcutaneous, intraperitoneal, intragastric, topical, and intramuscular
Storage
Store lyophilized powder at -20°C for long-term stability. Reconstituted solution should be stored at 2-8°C (refrigerated) and used within 30 days. Protect from light and avoid repeated freeze-thaw cycles.
Safety & Handling Information
For research use only. Not intended for human or veterinary diagnostic or therapeutic use.
Storage Requirements
- Lyophilized: -20°C, desiccated, protected from light
- Reconstituted: 2-8°C, use within 30 days
- Avoid repeated freeze-thaw cycles
Preclinical Safety Profile
BPC-157 has demonstrated a favorable safety profile in extensive rodent studies. No organ toxicity has been reported at standard research doses (up to 10 mcg/kg/day). LD50 has not been reached in acute toxicity studies, suggesting a wide therapeutic index in animal models.
Known Considerations
- Growth factor upregulation (VEGF, FGF) warrants caution in models involving neoplastic tissue or active angiogenesis
- Interaction with dopaminergic and nitric oxide systems may affect concurrent pharmacological studies targeting these pathways
- No known mutagenic or teratogenic effects in published literature, though reproductive toxicology data remains limited
Handling
Use standard laboratory PPE (gloves, lab coat, eye protection). Handle under aseptic conditions. Dispose of waste according to institutional biosafety guidelines for research peptides.
Frequently Asked Questions
What is BPC-157 and where does it originate?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a partial sequence of a protein found in human gastric juice. Unlike most bioactive peptides, BPC-157 is stable in gastric acid, making it unique among research peptides.
What purity level should I expect?
All BeaCapra BPC-157 is manufactured to ≥99% purity as verified by HPLC analysis. Each lot includes a Certificate of Analysis (COA) documenting purity, amino acid sequence verification via mass spectrometry, and endotoxin testing results.
How should I reconstitute BPC-157?
Add bacteriostatic water slowly to the lyophilized powder, directing the stream against the vial wall rather than directly onto the powder. Allow the peptide to dissolve without shaking. A 5 mg vial with 2 mL of water yields 2,500 mcg/mL.
Can BPC-157 be combined with other peptides in research?
BPC-157 has been studied alongside TB-500 (Thymosin Beta-4) in tissue repair research, with the two peptides acting through complementary mechanisms. However, co-reconstitution in the same vial is not recommended—prepare separate solutions to maintain stability.
What is the shelf life?
Lyophilized BPC-157 stored at -20°C is stable for up to 24 months. Once reconstituted with bacteriostatic water and stored at 2-8°C, the solution should be used within 30 days for optimal potency.
Related formulas
Customer Reviews
Exceptional purity and fast shipping
Third-party COA verified at 99.1% purity. Arrived in 2 days with proper cold packaging. The documentation included was thorough and professional. Will be ordering again for our lab.
Best supplier I've found
After trying several suppliers, BeaCapra consistently delivers the highest quality compounds. The subscribe & save option is a great value, and their customer support team answered all my questions promptly.
Great product, COA checks out
Ran our own HPLC analysis and confirmed the purity claims. Packaging was secure and discreet. Only minor note — would love to see more size options for some of the newer compounds. Otherwise excellent.
Subscribe & save is the way to go
The 15% discount on subscription makes this the most competitive pricing I've found for research-grade compounds at this purity level. Auto-delivery every 30 days has been seamless. Highly recommend.
Exactly what our research team needed
We've been sourcing from BeaCapra for our university lab and the consistency batch-to-batch is impressive. Every order comes with a COA and the compounds are properly lyophilized. Professional operation all around.
Questions About BPC-157
General Questions
Everything you need to know about BeaCapra research peptides, ordering, shipping, and our commitment to quality.
Still have questions? Our research specialists are here to help.
Contact Us